@article {Osborn871, author = {Eric A. Osborn and Chase W. Kessinger and Ahmed Tawakol and Farouc A. Jaffer}, title = {Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism}, volume = {58}, number = {6}, pages = {871--877}, year = {2017}, doi = {10.2967/jnumed.116.182873}, publisher = {Society of Nuclear Medicine}, abstract = {Metabolic and molecular imaging continues to advance our understanding of vascular disease pathophysiology. At present, 18F-FDG PET imaging is the most widely used clinical tool for metabolic and molecular imaging of atherosclerosis. However, novel nuclear tracers and intravascular optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in vivo and in coronary arteries. This review highlights current metabolic and molecular imaging clinical and near-clinical applications within atherosclerosis and venous thromboembolism, and explores the potential for metabolic and molecular imaging to affect patient-level risk prediction and disease treatment.}, issn = {0161-5505}, URL = {https://jnm.snmjournals.org/content/58/6/871}, eprint = {https://jnm.snmjournals.org/content/58/6/871.full.pdf}, journal = {Journal of Nuclear Medicine} }